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Background: Although CFRD is a complex disease which is best managed by
specialist services, in the UK access to the National Screening Program for Diabetic
Retinopathy (NSPDR) is traditionally made through primary care, where registered
patients attend a local RS facility. We enquire about RS attendance for our CFRD
patients at their annual screen, and were interested to identify any difﬁculties and
whether current practice is optimal.
Method: We randomly selected 50 CFRD patients attending our centre, and looked
at their complication rate and use of the NSPDR.
Results: Overall, 4 patients had diabetic retinopathy, 2 requiring specialist treat-
ment. However, only 25 had attended RS in the previous year (with 2 pending),
and we received formal correspondence following this in 5 cases (4 normal,
1 retinopathy). The CF team only became aware of the non-attendance of the
remaining 23 patients at their annual screen.
Conclusion: Despite the presence of serious CFRD complications, our results
show that many CFRD patients fail to attend for RS and this remains unnoticed.
Furthermore, there is a lack of communication between service providers that
disrupts the continuity of care for these patients. Reasons for this include the large
range of RS available facilities and the variation in policy of different healthcare
purchasers in the UK to allow registration for the NSPDR service. We are working
with purchasers to allow direct access and reporting for our team to these services
and recommend this to other CF units.
